| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699359 | Clinical Oncology | 2010 | 7 Pages |
Abstract
Adjuvant hysterectomy after unsuccessful ICBT does not seem to increase late toxicity and reduces the risk of pelvic recurrence and may improve survival. The role of adjuvant hysterectomy after suboptimal chemoradiation merits further investigation in clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N. Walji, A.L. Chue, C. Yap, L.J. Rogers, A. El-Modir, K.K. Chan, K. Singh, I.N. Fernando,